Lucía Berro Pizzarossa: 'Conditional use risks offering loophole to governments wary of embracing medical abortion'

An update on abortion pills from the World Health Organization undermines how the US regulates them. The update may make mifepristone and misoprostol more readily available worldwide. But in the US, not much is expected to change. Abortion pills should be widely available and affordable, and don't need to be dispensed by highly trained specialists or in specialty facilities, according to a World Health Organization update published last week. "Conditional use dependent on national law and cultural acceptability risks offering a loophole to governments wary of embracing medical abortion," Lucía Berro Pizzarossa, a researcher at the Global Health Law Groningen Research Centre in the Netherlands, says in the Pacific Standard. "These qualifications give states excuses to, for example, target organizations such as Aid Access that provide the medicines online."

This article was published by the Faculty of Law.